Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Our team is relentlessly focused on developing innovative treatments for rare and orphan diseases. Quoin’s pipeline comprises three unique products that collectively have the potential to target a broad number of indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa and others. We are committed to continuously expanding our pipeline of products to target additional rare and orphan diseases.
Quoin Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to supporting underserved patients, their families, communities, and care teams around the world.
View our latest news, download presentations, and sign up for
alerts to stay up to date on